Introducing Our New Business Director: Stephan Kerkojus

Introducing Our New Business Director: Stephan Kerkojus

We are thrilled to announce that Stephan Kerkojus has joined our team as our new Business Director. With a wealth of experience and a track record of driving business growth, Stephan Kerkojus is set to play a pivotal role in shaping our company’s future. A Strong...
Together with Bencard Allergie GmbH, Munich, Germany, ClinCompetence Cologne publishes the top line results of the first year of the 5-years cohort study TAPAS (Tyrosine Allergoid paediatric and adult study)

Together with Bencard Allergie GmbH, Munich, Germany, ClinCompetence Cologne publishes the top line results of the first year of the 5-years cohort study TAPAS (Tyrosine Allergoid paediatric and adult study)

The TAPAS study (“Tyrosine Allergoid Paediatric and Adult Study”) is a large, prospective, multicenter, long-term cohort study designed to evaluate the safety, tolerability, and efficacy of subcutaneous allergen immunotherapy (SCIT) with microcrystalline tespecially...